Cyclo Therapeutics Inc (CYTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,247 | 1,543 | 16,613 | 12,846 | 2,784 |
| Receivables | 122 | 55 | 493 | 71 | 143 |
| Inventories | 254 | 255 | 227 | 238 | 243 |
| Other current assets | 0 | 0 | 46 | 41 | 39 |
| TOTAL | $12,318 | $4,159 | $19,436 | $14,050 | $3,958 |
| Non-Current Assets | |||||
| PPE Net | 38 | 55 | 60 | 54 | 14 |
| Other Non-Current Assets | 891 | 2 | 25 | 84 | 142 |
| TOTAL | $929 | $57 | $85 | $138 | $155 |
| Total Assets | $13,248 | $4,215 | $19,521 | $14,188 | $4,113 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,457 | 3,481 | 3,678 | 3,541 | 3,125 |
| TOTAL | $8,468 | $3,481 | $3,831 | $3,673 | $3,141 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 18 | 45 | N/A |
| Other Non-Current Liabilities | 23 | 0 | 0 | 18 | 36 |
| TOTAL | $23 | $N/A | $18 | $63 | $36 |
| Total Liabilities | $8,491 | $3,481 | $3,849 | $3,736 | $3,177 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 28,716 | 10,555 | 8,405 | 6,293 | 1,217 |
| Common Shares | 3 | 1 | 1 | 1 | 0 |
| Retained earnings | -83,857 | -63,799 | -48,349 | -34,062 | -25,120 |
| TOTAL | $4,757 | $735 | $15,672 | $10,453 | $936 |
| Total Liabilities And Equity | $13,248 | $4,215 | $19,521 | $14,188 | $4,113 |